Our Pipeline

  • DIANA assay has been already developed and validated for 3 targets in diagnostic mode and for 10 targets in screening mode
  • We focus on medically relevant enzymes and receptors (incl. multiple onco-markers)
  • Examples of targets include: Carbonic Anhydrase family, Prostate Specific Membrane Antigene or Insulin receptor
  • In addition to our internal R&D pipeline, we are developing DIANA assays to new targets on demand – assay development is fast and straightforward
TargetDevelopment statusProducts available
Development initiatedProbe synthesized & testedAssay validated - available for licensingScreening
EnzymesProstate specific membrane antigen (PSMA/GCPII) YESYES
Glutamate carboxypeptidase III (GCPIII) YES
Carbonic anhydrase II
Carbonic anhydrase VII YES
Carbonic anhydrase IX YESYES
Carbonic anhydrase XII
Fibroblast activating protein (FAP) YESYES
Neuraminidase N1 strain (A/California/07/2009) YES
RNA polymerase from Influenza A/California/07/2009
17beta-hydroxysteroid dehydrogenase 1 (17beta-HSD1)
DNA methyl transferases
Pan-kinase panel
ReceptorsInsulin receptor YES
Insulin-like growth factor receptors


DIANA Biotechnologies s.r.o.
Nad Safinou II 366
252 50 Vestec
Czech Republic